Categories: Bull Market Alert HotlinesStock Market News

Booking 57.54% Gains in Jazz Pharmaceuticals

Jazz Pharmaceuticals (JAZZ) jumped 2.56% yesterday.

Jazz, whose drugs include treatments for pain and narcolepsy, reports Q2 results after today’s close. Analysts forecast a 39% increase in earnings to $1.52 a share. Sales for the period are expected to jump 68% to $208.7 million.

With your September 2013 $70 call options (JAZZ130921C00070000) now up 57.54%, I recommend that you sell half of your options here to lock in solid gains ahead of tonight’s earnings announcements.

With the JAZZ stock up 34.82% since my initial recommendation, raise your stop to $75.50 to lock in at least a 30% gain in the stock.

Exclusive Slow GO: Is a Bear Market and Hard Landing Coming?

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world. He was the Editor of The Global Guru, a free weekly e-newsletter, and also edited the trading services Momentum Trader Alert, which focused on making short-term profits in the hottest markets in the world, and The Alpha Algorithm, which was designed specifically to deliver big, fast triple-digit winners, month after month. He was also the editor of Smart Money Masters, a monthly service focused on longer term investments recommended by the brightest minds in the business. Mr. Vardy has been a regular commentator on CNN International and the Fox Business Network. He has also published articles in The New Republic, The World and I, and The Baker & McKenzie Legal Review. The Global Guru/Nicholas Vardy has been cited in The Wall Street Journal, Newsweek, Fox Business News, CBS MarketWatch, Yahoo! Finance, and MSN Money Central. Mr. Vardy graduated from Stanford with a B.A. — with honors and distinction — in both Economics and History, and he also earned an M.A in Modern European Intellectual History. After winning a Fulbright Scholarship, he earned a J.D. degree at Harvard Law School where he was an editor of the Harvard International Law Journal. When not uncovering investment opportunities for his subscribers and investors, Mr. Vardy is a keep-fit enthusiast and an avid student of classical music.